Épron Quievy & Associé advised Paltech SAS within it’s second fundraising
After a first fundraising in 2021, Paltech SAS closed in October 2023 a new round of more than one million euros fully subscribed by private investors.
Founded by doctors Réginald Allouche and Charles-Henri Malbert in 2021, Paltech SAS is an innovative company dedicated to the research for a curative treatment for type 2 diabetes.
Type 2 diabetes is a developing disease that affects more than 800 million people worldwide. The complications induced by this disease both in medium and long terms are strongly disabling. Type 2 diabetes is notably the main cause in non-traumatic amputations, blindness, kidney failure and neuropathy. Most treatments currently available are palliative and allow individuals to live with the disease without curing it. Paltech is developing a medical device that under certain conditions might cure people with type 2 diabetes. The first experiments made it possible to validate the proof of concept. Clinical trials with human beings are planned to start in 2025.
Paltech SAS is assisted by Épron Quievy & Associés on a day-to-day basis with Étienne Épron, partner and Cassandra Gimbert, associate.
More info on Paltech http://www.paltech.fr
Latest news
-
,
-
April 4, 2025
EQA Avocats assisted Pozzi Milano S.p.A. in the acquisition of a majority stake in Venditio SAS
After several months of negotiations, the Italian company Pozzi Milano SPA, specialized in the production of tableware, purchased 90% of the share capital of Venditio SAS, its commercial agent for France and Belgium. On March 21, 2025, the transaction was finalized. The acquisition of the remaining 10% of the share capital may take place until… Continue reading EQA Avocats assisted Pozzi Milano S.p.A. in the acquisition of a majority stake in Venditio SAS
April 2, 2025
EQA Avocats Honoured at the Le Monde du Droit Awards 2025
For the first time, EQA Avocats took part in the Le Monde du Droit law firm rankings and had the honour of receiving two distinctions in the category of firms with fewer than 10 lawyers: • Private Equity – Gold• Mergers & Acquisitions < €50 million – Bronze These awards are the result of collective,… Continue reading EQA Avocats Honoured at the Le Monde du Droit Awards 2025
March 6, 2025
Sanctions: When the Fight for “Our Values” Tramples “Our Values”
Étienne Épron published a column in Omerta magazine on March 5, 2025. The full version in French can be found in the special edition Omerta, Hors-Série No. 2: “Ukraine, la guerre sans fin”.
February 21, 2025
Étienne Épron at the Annual Conference of Université Paris Dauphine
On March 13, 2025, at 6:45 PM, Étienne Épron, managing partner at EQA Avocats and a specialist in international sanctions, will take part in the annual conference of the Master 212 program at Université Paris Dauphine, titled: “De-dollarization: Can the World Function Without the Dollar? BRICS and the Dollar: Challenging American Hegemony.” This event will… Continue reading Étienne Épron at the Annual Conference of Université Paris Dauphine